Rationale Aspects of schizophrenia, including deficits in sensorimotor gating, have been linked to glutamate dysfunction and/or oxidative stress in the prefrontal cortex. System x c −
Introduction
Abnormal activity within the prefrontal cortex has been linked to schizophrenia and may contribute to aspects of the disease that are only marginally responsive to existing antipsychotic medications (Berman et al. 1986; Garey et al. 1998; Glantz and Lewis 2000; Lieberman et al. 2005; Rajkowska et al. 1998) . Dysregulation of excitatory signaling has been widely linked to deficits in prefrontal cortical activity observed in schizophrenia (Bunney and Bunney 2000; Javitt et al. 2011; Moghaddam and Javitt 2012) , although the nature of the potential pathological changes are not clear. Reduced, increased, or desynchronized excitatory activity in the prefrontal cortex has been proposed to occur in schizophrenia (Franzen and Ingvar 1975; Ingvar and Franzen 1974; Jackson et al. 2004; Moghaddam and Adams 1998; Potkin et al. 2009 ). Identifying the cellular basis of prefrontal deficits in more detail, especially as it relates to excitatory signaling, will advance our understanding of the neurobiology of schizophrenia and possibly reveal novel therapeutic targets.
The equivocal nature of excitatory signaling in relation to abnormal prefrontal cortical activity may stem from critical gaps in our understanding of glutamate. Although often described as the primary excitatory neurotransmitter in the brain (Coyle and Puttfarcken 1993; Marino et al. 2001) , we are only now unmasking how the many components of this complex network of receptors, membrane-expressed enzymes, transporters, and release mechanisms function in an integrated manner to regulate the neurotransmitter actions of this amino acid. Extant data indicate the existence of multiple glutamate release mechanisms by astrocytes (Araque et al. 2000; Bezzi et al. 1998; Parpura et al. 1994; Pasti et al. 2001; Ye et al. 2003 ) that may independently maintain glutamate concentrations in distinct compartments (e.g., synaptic and extrasynaptic; Bridges et al. 2012) . If this is the case, a hypo-and hyperglutamatergic state may exist in these separate compartments.
System x c − is an example of a poorly understood regulator of glutamate homeostasis that may exert profound control over multiple aspects of synaptic function (Baker et al. 2002; Moran et al. 2005; Moussawi et al. 2009 Moussawi et al. , 2011 . Originally identified over 30 years ago as a sodiumindependent glutamate transporter (Bannai and Kitamura 1980) , system x c − functions as a cystine-glutamate antiporter or exchanger that couples the uptake of one molecule of extracellular cystine to the release of one molecule of intracellular glutamate (Bannai 1986; Piani and Fontana 1994) . Nonvesicular glutamate release by system x c − regulates synaptic activity by stimulating extrasynaptic receptors including inhibitory group II metabotropic glutamate receptors (Baker et al. 2002; Kupchik et al. 2011; Moran et al. 2005; Pow 2001 ), which is thought to then inhibit synaptic neurotransmitter release (Battaglia et al. 1997; Moran et al. 2005) . Thus, manipulations of system x c − activity could differentially impact levels of extracellular glutamate in extrasynaptic and synaptic compartments. An important question to be addressed is whether increased system x c − activity in the prefrontal cortex is sufficient to manipulate behaviors thought to stem from excitatory signaling within the prefrontal cortex, especially since extant data suggest that system x c − activity in the prefrontal cortex may be altered in schizophrenia Do et al. 2000; Raffa et al. 2011) .
The purpose of the current set of studies was to determine whether system x c − activity in the prefrontal cortex may influence sensorimotor gating, in part because it may be altered in schizophrenia as a result of abnormal excitatory signaling in the prefrontal cortex (Koch and Bubser 1994; Kumari et al. 2008; Majic et al. 2011; Swerdlow et al. 2001; Wilmsmeier et al. 2010) . Sensorimotor gating refers to the ability of the central nervous system to regulate the capacity of sensory information to influence behavior (Braff and Geyer 1990; Graham 1974; Swerdlow et al. 1986) . It is often assessed in rodents using prepulse inhibition, which involves measuring the inhibition of a startle response when the onset of the startle-eliciting auditory stimuli is indicated to the subject by a preceding, relatively mild acoustic stimulus. Attempts to reveal the neural basis of sensorimotor gating deficits in schizophrenia often involve the use of noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists, such as phencyclidine, to disrupt prepulse inhibition of an acoustic startle response (Braff et al. 1978; Geyer et al. 2001; Swerdlow et al. 2006 ).
Materials and methods
Animals and surgeries Male Sprague-Dawley rats (Harlan, Indianapolis, IN, USA) weighing 300-400 g were individually housed in a temperature controlled room with a 12-h light/ dark cycle with food and water ad libitum. The housing conditions and care of the rats were in accordance with the Animal Welfare Act, and all procedures were approved by the Marquette University IACUC Committee. The total number of rats used in these experiments was 172; each rat was tested only once. Rats used in the microdialysis studies were anesthetized using pentobarbital (50 mg/kg, IP) with atropine sulfate (1 mg/kg, IP) pretreatment to limit tracheobronchial secretions. One pair of bilateral guide cannula (20 ga, 14 mm; Plastics One, Roanoke, VA, USA) were implanted using coordinates (+3.1 mm anterior, ±1.0 mm mediolateral to Bregma, and −0.75 mm ventral from the surface of the skull at a 6°angle from vertical) derived from Paxinos and Watson (1986) . Following surgery, rats were provided acetaminophen (480 mg/L) in their drinking water for 2 days and were given at least 6 days to recover prior to testing.
In situ hybridization Brains were rapidly removed and frozen in optimal cutting temperature solution (OCT, Sakura, Torrance, CA, USA) in a dry ice and ethanol bath and then cut into 12-μm coronal sections. Standard in vitro transcription methods were used to generate riboprobes against xCT (Choi, Milwaukee, WI, USA), which was subsequently diluted in hybridization cocktail (Amresco, Solon, OH, USA) and transfer RNA (tRNA). Sections were hybridized overnight at 55°C in a mixture of tRNA, formamide, dextran, NaCl, EDTA, Denhardt's solution, and 33 P-labeled riboprobe. After hybridization, slides were rinsed in 2× saline-sodium citrate (SSC) buffer (pH7.0). They were treated with RNase A in a 0.5-M sodium chloride, 10 mM Tris, 1 mM EDTA buffer for 30 min at 37°C and then washed in the same buffer without RNase A for 30 min at 37°C. Slides were stringently washed in 0.5× SSC for 30 min at 6°C and then exposed to autoradiographic film (3 days) and then subsequently coated with Kodak autoradiographic emulsion NTB (Rochester, NY, USA) and exposed for 9 days to produce silver grains. Following standard autoradiography development, NTB emulsion-dipped sections were counterstained with 0.5 % cresyl violet. Photodocumentation of silver grains was achieved using dark field microscopy (Axioskop-2, Zeiss, Thornwood, NY, USA) and Axiovision image analysis software (Zeiss, Thornwood, NY, USA).
[
14 C]Cystine Uptake Rats were decapitated, and the brains were rapidly extracted and cut into 1 mm coronal slices using a brain matrix. Tissue punches (1.25 mm diameter, Stoelting, Wood Dale, IL, USA) were collected from the medial prefrontal cortex and incubated at 37°C for approximately 30 min on a nylon bolting cloth platform, submerged beneath 2 mm of standard buffer (Lobner and Lipton 1993) ; the standard buffer contained 124 mM NaCl, 3.0 mM KCl, 1.4 mM KH 2 PO 4 , 1.3 mM MgSO 4 , 26 mM NaHCO 3 , 2.4 mM CaCl 2 , and 4 mM glucose, equilibrated with 95 % O 2 , 5 % CO 2 ; pH was 7.4. After a 30-min wash, the tissue was incubated for 10 min in standard buffer containing phencyclidine (0 or 3 μM) or the system x c − inhibitor (S)-4-carboxyphenylglycine (CPG; 0 or 1 mM). 14 C-Cystine (0.03 μCi/mL; PerkinElmer, Boston, MA, USA) and DL-threo-β-benzyloxyaspartic acid (10 μM; to prevent the uptake of cystine via X AG ) was then added to the incubation buffer for 10 min. Next, the tissue punches were washed four times in ice-cold standard buffer and dissolved in 250 μL of 1 % sodium dodecyl sulfate. One aliquot (100 μL) was used to measure 14 C-cystine uptake by scintillation counting; a second aliquot (100 μL) was used to assess protein content by the BCA method. Cystine uptake (CPM/g protein) was normalized to the vehicle group run concurrently (i.e., in the same plate).
In vivo drug treatments Phencyclidine (0-3 mg/kg; NIDA Drug Supply Program, Research Triangle, NC, USA) was dissolved in isotonic saline. N-Acetylcysteine (0-100 μM, Sigma Chemical Co., St Louis, MO, USA) and CPG (0.5 μM; Tocris-Cooksin, Ellisville, MO, USA) was dissolved in microdialysis buffer.
Prepulse inhibition Rats were placed on a platform in a sound attenuating chamber (27.62×35.56×49.53 cm); Hamilton Kinder, CA, USA) that rested on a motion sensing plate. A matching session was conducted to determine the magnitude of the startle response for each rat. This session consisted of a 5-min habituation period followed by 20 trials; 17 trials involved the presentation of a single auditory stimulus (pulse stimulus; 50 dB above the 60 dB background noise, 40 ms duration) and three trials in which a prepulse stimulus (12 dB above background, 20 ms duration) was presented 100 ms before the pulse stimulus. Rats were then assigned into the various treatment groups based on the magnitude of their startle response. At least 1 day later, an experimental session was conducted to assess sensorimotor gating. On this day, rats received a 5 or 10 min habituation period followed by 58 discrete trials; eight background trials with only background noise, 26 trials with only the pulse stimulus (50 dB above background), and 24 trials with the pulse stimulus being preceded by one of three prepulse stimuli (2, 6, or 15 dB above background). The percent of prepulse inhibition was determined as 100−(average prepulse startle response/average startle stimulus alone)×100.
In vivo microdialysis Microdialysis probes were constructed as previously described (Baker et al. 2002) . The active membrane, approximately 1 mm in total length, began 1 mm beyond the most distal aspect of the guide cannula to minimize the influence of tissue damaged by the guide cannula to our measures. Dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM CaCl 2 , 1.2 mM MgCl 2 , and 0.15 % phosphate buffer saline, pH7.4) was pumped through the probes at a rate of 1 μL/min. Drugs were administered as described below for each experiment. Reverse dialysis was used for local infusions since it permits delivery of a low concentration of a drug (especially when considering an average recovery rate of 7 % that is typical of our probes) across time as well as across the dorsal-ventral axis of the prefrontal cortex.
Histology Rats included in the microdialysis studies were given an overdose of pentobarbital (60 mg/kg, IP), and the brains were fixed by intracardiac infusion of 0.9 % saline followed by 2.5 % formalin solution. Brains were removed and stored in 2.5 % formalin for at least 7 days prior to sectioning. The tissue was then blocked and coronal sections (100 μm) were cut and stained with cresyl violet to verify probe placements. Rats determined to have misplaced guide cannula were excluded from all behavioral analyses.
Statistics Primary comparisons involving only two groups (i.e., experimnets 1 and 5) were analyzed using an independent sample t test. Primary comparisons involving more than two groups were analyzed using ANOVA with drug treatment (i.e., phencyclidine, N-acetylcysteine) as betweensubject factors and prepulse intensity as a repeated measure. The presence or absences of CPG was used as an additional between subjects variable used in experiment 4. Significant interactions and main effects were further analyzed using Tukey honestly significant difference (HSD) (p<0.05).
Design of experiment 1 This experiment was designed to characterize system x c − in the prefrontal cortex. First, we used in situ hybridization to determine the distribution of messenger RNA (mRNA) of xCT, the active subunit for system x c − . Next, we measured 14 C-cystine uptake in ex vivo tissue punches obtained from the prefrontal cortex in the absence or presence of the system x c − inhibitor CPG to confirm the existence of cystine-glutamate exchange by system x c − .
Design of experiment 2 The purpose of this experiment was to select a dose of phencyclidine for subsequent experiments. Rats received an acute injection of phencyclidine (0-3 mg/kg, SC) 10 min before being placed in the startle chamber. Testing was conducted as described above.
Design of experiment 3 This experiment was designed to determine the impact of increased cystine-glutamate exchange on phencyclidine-induced deficits in prepulse inhibition. To do this, we reverse dialyzed the cysteine prodrug N-acetylcysteine (0-100 μM) directly into the prefrontal cortex for 1 h prior to and after phencyclidine (0 or 1.5 mg/kg, sc) administration. One hour after phencyclidine, the probes were removed, and rats underwent prepulse inhibition testing as described above.
Design of experiment 4 This experiment was designed to verify that N-acetylcysteine antagonizes phencyclidineinduced deficits in prepulse inhibition by increasing system x c − activity in the prefrontal cortex. To do this, the system x c − inhibitor CPG (0 or 0.5 μM), was infused into the prefrontal cortex. Twenty minutes later, N-acetylcysteine (0 or 30 μM) was added to the dialysis buffer such that CPG and N-acetylcysteine were coinfused until prepulse inhibition testing. One hour after CPG and N-acetylcysteine treatment began, phencyclidine was administered (0-1.5 mg/kg, sc). One hour postphencyclidine, the probes were removed and rats underwent prepulse inhibition testing as described above.
Design of experiment 5 This experiment was used to determine whether phencyclidine directly influences the rate of cystine-glutamate exchange by system x c − . To do this, we measured the uptake of 14 C-cystine uptake in prefrontal cortical tissue punches incubated in the absence (N09) or presence (N07) of phencyclidine (3 μM). The concentration of phencyclidine chosen exceeds estimates of NMDA receptor affinity for this compound by 3-15-fold (Morris et al. 2005) .
Results

System x c
− appears to be differentially expressed across subregions of the prefrontal cortex. The distribution of xCT mRNA within the prefrontal cortex reveals a particularly prominent lateral band of xCT mRNA contained primarily in the prelimbic cortex (see Fig. 1 ). The uptake of 14 C-cystine by tissue punches obtained from this subregion of the prefrontal cortex was significantly reduced by the system x c − inhibitor CPG [t (14) 012.4, p<0.001] revealing the existence of functional cystine-glutamate exchange by system x c − in this region.
Phencyclidine produced a dose-dependent impairment in prepulse inhibition of the acoustic startle reflex (see Fig. 2 ). An ANOVA with drug treatment as a between subjects variable and prepulse intensity as a repeated measure yielded a significant interaction [F (12,102) 05.77, p<0.001]. Analysis of the simple main effects revealed a significant main effect of drug treatment at prepulse intensities of six [F (6,57) 09.20, p < 0.001] and 15 dB [F (6,57) 014.79, p < 0.001], but not 2 dB [F (6,57) 00.40, p00.88]. Post hoc analyses indicated that phencyclidine produced deficits in prepulse inhibition at doses exceeding 1 mg/kg (Tukey, p< 0.05). A main effect of phencyclidine treatment [F (6,57) analysis revealed that phencyclidine dose-dependently (1.25, 2.0 mg/kg) altered startle magnitude (Table 1 ; Tukey, p<0.05). Figure 3a depicts the impact of N-acetylcysteine infused into the medial prefrontal cortex via reverse dialysis on phencyclidine-induced deficits in sensorimotor gating. An ANOVA with drug treatment as a between subjects variable and prepulse intensity as a repeated measure yielded a significant interaction [F (8,54) 02.26, p<0.05]. Analysis of the simple main effects revealed a significant effect of drug at every prepulse intensity [2 dB, F (4,31) 04.12, p00.01; 6 dB, F (4,31) 010.70, p<0.001; 15 dB, F (4,31) 07.15, p< 0.001]. Post hoc analyses indicated that phencyclidineinduced impairment of sensorimotor gating was attenuated by N-acetylcysteine at every prepulse intensity ( Fig. 4 ; Tukey, p<0.05). There were no significant differences in the startle amplitude between the groups included in this study [ANOVA, F (4, 33) 00.21, p>0.05, Table 1 ]. The subregion of the prefrontal cortex targeted in the microdialysis studies is depicted in Fig. 3b . Figure 4 demonstrates that N-acetylcysteine antagonizes phencyclidine-induced deficits in prepulse inhibition by increasing cystine-glutamate exchange from system x c − . An ANOVA with drug treatments (i.e., N-acetylcysteine and PCP treatment) as between subjects variables and prepulse intensity as a repeated measure produced a significant interaction between CPG treatment and drug treatment [F (1,46) 04.57, p<0.05]. To further deconstruct the interaction, we examined the simple main effect of drug treatment at each level of the CPG variable. In the absence of CPG, an ANOVA with drug treatment as a between subjects variable and prepulse intensity as a repeated measure yielded a significant interaction between these variables [F (4,42) 03.01, p<0.05]. Analysis of the simple main effects revealed a significant main effect of drug treatment at every prepulse intensity [2 dB, F (2,23) 012.41, p<0.001; 6 dB, F (2,23) 013.82, p<0.001; 15 dB, F (2,23) 012.35, p<0.001). Post hoc analyses indicated that N-acetylcysteine antagonized phencyclidineinduced deficits in prepulse inhibition when tested in the absence of CPG ( Fig. 4a ; Tukey, p<0.05). In the presence of CPG, a two-way ANOVA including treatment (N-acetylcysteine and phencyclidine treatments) as the between subjects variable and prepulse intensity as the repeated measures yielded a significant main effect of treatment [F (2,24) 010.35, p<0.001] in the absence of a significant interaction between treatment and prepulse intensity [F (4,48) 01.91, p>0.05]. Post hoc analyses indicated that N-acetylcysteine failed to alter phencyclidineinduced deficits in prepulse inhibition when tested in the Fig. 2 Phencyclidine produces a dose-dependent disruption of prepulse inhibition. The data are expressed as the mean (+SEM) percent inhibition of the startle response to a loud auditory stimulus when preceded by a mile-modest, nonstartle-eliciting auditory cue ranging between 2 and 15 dB. Behavior depicted was obtained from rats that had received an acute injection of phencyclidine (PCP, 0-3 mg/kg; SC) 10 min prior to testing. *p<0.05, difference from controls receiving 0 mg/kg phencyclidine (Tukey HSD) Fig. 4b ; Tukey, p>0.05). There were no significant differences in the startle amplitude between the groups included in this study [F (2,23) The mean values (±SEM) for vehicle and phencyclidine-treated tissue punches were 100±9.9 and 83± 9.2, respectively. These data indicate that glutamate dysfunction produced by phencyclidine does not likely involve altered activity of system x c − in the prefrontal cortex.
Discussion
Abnormal glutamatergic signaling particularly in cortical structures has been linked to negative symptoms and a The mean (+SEM) prepulse inhibition displayed by rats receiving N-acetylcysteine (NAC, 0-100 μM) into the prefrontal cortex followed 1 h later by an acute injection of phencyclidine (0 or 1.5 mg/kg, SC). *p<0.05, significant difference from control rats receiving only saline (NAC 0/ PCP 0; Tukey HSD). Plus symbol indicates significant difference from rats receiving only phencyclidine (NAC 0/PCP 1.25; Tukey HSD, p< 0.05). b The microdialysis probes were placed primarily in the prelimbic cortex (PrL), although aspects of the infralimbic (IL) may have been perfused as well. A representative coronal section illustrates the placement of a microdialysis probe. The tract created extends approximately 2 mm from the guide cannula with sampling only occurring from the most ventral 1 mm because this is the portion of the probe containing the dialysis membrane Fig. 4 N-Acetylcysteine targets system x c − to antagonize deficits in prepulse inhibition produced by phencyclidine. The data are expressed as mean (+SEM) prepulse inhibition displayed by rats receiving intraprefrontal N-acetylcysteine (30 μM) a in the absence or b presence of the system x c − inhibitor CPG (0.5 μM) coinfused into the prefrontal cortex. CPG was infused alone for 20 min, N-acetylcysteine was then added to the microdialysis buffer for 60 min prior to the injection of phencyclidine (1.5 mg/kg, sc). a, b *p<0.05, significant difference from respective vehicle controls (i.e., rats receiving NAC 0/PCP 0; Tukey HSD). Plus symbol indicates a significant difference from respective phencyclidine controls (NAC 0/PCP 1.5; Tukey HSD, p<0.05) cognitive deficits present in schizophrenia (Bunney and Bunney 2000; Deserno et al. 2012; Goghari et al. 2010; van Veelen et al. 2010) . As a result, identifying cellular mechanisms capable of regulating glutamate signaling may advance our understanding of the neurobiological basis of schizophrenia and facilitate the development of pharmacotherapies. System x c − , which exchanges extracellular cystine for intracellular glutamate (Bannai 1986; Bridges 2012) , is a poorly understood regulator of glutamate homeostasis that may exert profound control over multiple aspects of synaptic function (Baker et al. 2002; Moran et al. 2005; Moussawi et al. 2009 Moussawi et al. , 2011 and may be altered in schizophrenia Bridges et al. 2012) . The primary finding of the present report is that infusion of the cysteine prodrug Nacetylcysteine into the prefrontal cortex attenuates phencyclidine-induced deficits in sensorimotor gating, and this effect is dependent upon intact system x c − activity.
Collectively, these data illustrate the capacity of system x c − to regulate a complex behavior involving the prefrontal cortex. Below, we discuss the potential relevance of this data set to our understanding and potential treatment of schizophrenia.
In the current study, infusion of N-acetylcysteine into the prefrontal cortex antagonized phencyclidine-induced deficits in prepulse inhibition. The effects of N-acetylcysteine on prepulse inhibition are likely due to increased activity of system x c − in the prefrontal cortex, particularly within the prelimbic region of this structure. To establish this, we first verified the existence of system x c − in the prefrontal cortex by demonstrating the presence of mRNA for xCT, the active subunit of system x c − , and functional cystine-glutamate exchange in prefrontal cortical tissue. Next, we found that reverse dialysis of N-acetylcysteine directly into this region antagonized phencyclidine-induced deficits in prepulse inhibition, an effect not observed when the system x c − inhibitor CPG was coinfused. This finding is similar to our previous observations that N-acetylcysteine required intact system x c − activity to alter multiple behaviors including phencyclidine-induced deficits in working memory Kau et al. 2008) . Interestingly, this could stem from either the release of glutamate or the increase in intracellular thiols expected from increased system x c − activity (Baker et al. 2002; Bridges et al. 2012; Shimosato et al. 1995) , which is expressed on astrocytes (Pow 2001) . It is important to note that studies demonstrate the possibility that glutathione, a thiol that is dependent upon the transport of cystine for de novo synthesis, is capable of functioning as a signaling molecule (Janaky et al. 1999; Ogita et al. 1995) , and has been shown to influence excitatory signaling (Baker et al. 2002; Moran et al. 2005) . In either case, the data are consistent with the conclusion that astrocytes may be a key in regulating the activity of the prefrontal cortex in a manner that alters complex behaviors. Interestingly, activation of astrocytes has recently been shown to synchronize the firing large numbers of neurons through a glutamate-dependent manner (Angulo et al. 2004; Poskanzer and Yuste 2011) . Thus, an important area of future research is the degree to which system x c − may be involved in these phenomena, especially since the origin of the glutamate may be nonvesicular (Angulo et al. 2004 ). The present data may also have implications for our understanding and treatment of schizophrenia. Phencyclidineinduced deficits in prepulse inhibition has been used to study the neural basis of sensorimotor gating deficits observed in schizophrenia as well and to screen putative therapeutics that may exert antipsychotic effects Swerdlow et al. 2008) . However, the constructive validity of the phencyclidine model is questionable given that there are likely to be critical distinctions between the basis of abnormal behaviors produced by acute administration of phencyclidine and a chronic illness such as schizophrenia. In addition, the predictive validity of this model may also be questioned given that a number of currently used antipsychotics fail to alter phencyclidine-induced deficits in numerous behaviors, including prepulse inhibition. To this latter point, however, the inability of most currently used antipsychotics to significantly improve prepulse inhibition deficits produced by phencyclidine may parallel the poor efficacy of these medications in treating numerous symptoms associated with schizophrenia, particularly those thought to involve, at least in part, the prefrontal cortex such as sensorimotor gating and cognitive deficits (Japha and Koch 1999; Kumari et al. 2008; Swerdlow et al. 2001) . In support, clozapine, which appears unique from other antipsychotics in that it significantly reduces sensorimotor gating and cognitive deficits in schizophrenia (Oranje et al. 2002) , also has been shown to attenuate phencyclidineinduced deficits in prepulse inhibition (Bakshi et al. 1994; Geyer et al. 2001; Li et al. 2011) , but see (Cilia et al. 2007; Schwabe et al. 2005 ).
An important question is the possibility that altered system x c − function may be evident in schizophrenia and, if so, whether any potential disruption might impact the therapeutic utility of this target. In the current study, we did not find evidence that the psychotomimetic phencyclidine disrupted system x c − activity, although, as discussed above, there likely are key distinctions between abnormal behaviors produced by schizophrenia and acute phencyclidine administration. Furthermore, we cannot rule out the possibility that phencyclidine alters system x c − activity under certain conditions (e.g., in vivo) or in a tissue-specific manner (e.g. cell type or brain region). Regardless, in schizophrenia, glutathione levels in the dorsolateral prefrontal cortex are significantly reduced (Do et al. 2000) , which may indicate reduced system x c − . The reason for this is that intracellular cystine availability is thought to be the rate-limiting step in the synthesis of this key antioxidant (Kranich et al. 1998; Sagara et al. 1993) . Perhaps as a result of the decrease in glutathione, the protein levels of xCT, the active subunit for system x c − , is significantly increased in the dorsolateral prefrontal cortex in postmortem tissue obtained from individuals afflicted with schizophrenia relative to controls . In support, decreased glutathione levels has been shown to be sufficient to upregulate system x c − (Seib et al. 2011) . At the very least, these studies indicate that stimulation of system x c − is a potential therapeutic target for schizophrenia, which has been verified in a clinical trial (Berk et al. 2008) .
Because system x c − is at the interface between oxidative stress and excitatory signaling, it is unclear how N-acetylcysteine reduces behavioral and neurochemical measures in rodents that may be relevant for schizophrenia Chen et al. 2010; das Neves Duarte et al. 2012) or the actual symptoms of the disease in man (Berk et al. 2008; Berk et al. 2011) . Specifically, system x c − couples the uptake of extracellular cystine to the release of intracellular glutamate (Baker et al. 2002; Bannai 1984; Bridges 2012; Cho and Bannai 1990) . Evidence implicating the glutamate component of cystine-glutamate exchange include observations that system x c − regulates multiple aspects of synaptic activity including extracellular glutamate levels, activation levels of glutamate receptors, and synaptic plasticity (Baker et al. 2002; Kupchik et al. 2011; Moran et al. 2005; Moussawi et al. 2009 . In addition, astrocytes have been shown to synchronize the activity of large numbers of neurons through a glutamate-dependent mechanism (Angulo et al. 2004; Poskanzer and Yuste 2011) . The potential significance of the latter point is evident from estimates that human cortical astrocytes may contact millions of neurons (Oberheim et al. 2006) . Thus, increased glutamate release from system x c − may reverse several cellular events linked to schizophrenia ranging from NMDA receptor hypofunction to desynchronized firing of pyramidal neurons in the cortex. Evidence implicating the cystine-component of cystineglutamate exchange in the therapeutic effects of N-acetylcysteine stems largely from observations that (1) schizophrenia is associated with an imbalance in levels of antioxidants such as glutathione, the synthesis of which is at least partially dependent on system x c − as described above, and reactive oxygen species, or (2) depletion of glutathione in rodents recreates aspects of schizophrenia (Cabungcal et al. 2007; Gysin et al. 2011; Kulak et al. 2012; Steullet et al. 2006) . In support, a decrease in glutathione inversely correlates with the severity of negative symptoms (Matsuzawa et al. 2008) . Surprisingly, however, N-acetylcysteine has been shown to restore numerous interesting neurochemical abnormalities in glutathionedeficient mice without restoring glutathione levels (das Neves Duarte et al. 2012) . Interestingly, the cystine and glutamate components of system x c − may converge on key cellular events thought to underlie aspects of schizophrenia, as demonstrated by the observation that depletion of glutathione is sufficient to produce NMDA receptor hypoactivity (Steullet et al. 2006) . Collectively, these studies indicate that the study of system x c − may have profound impact on the integration of important components of neurophysiology such as excitatory signaling and oxidative stress that are often studied in isolation as well as our ability to understand and treat debilitating central nervous system disease states such as schizophrenia.
